Odontoprev S.A. (BVMF:ODPV3)

Brazil · Delayed Price · Currency is BRL

14.59

-0.11 (-0.75%)

Apr 28, 2026, 5:07 PM GMT-3

36.61% (1Y)

Market Cap	8.01B
Revenue (ttm)	2.55B
Net Income (ttm)	582.57M
Shares Out	545.09M
EPS (ttm)	1.07
PE Ratio	13.76
Forward PE	14.11
Dividend	0.81 (5.53%)
Ex-Dividend Date	Dec 19, 2025

Volume	3,091,300
Average Volume	4,895,080
Open	14.67
Previous Close	14.70
Day's Range	14.38 - 14.67
52-Week Range	10.39 - 16.57
Beta	0.55
RSI	52.12
Earnings Date	May 4, 2026

About Odontoprev

Odontoprev S.A. provides private dental care plans in Brazil. The company operates through Corporate, Small and Medium-Sized Enterprise (SME), Individual, and Other segments. The company manages and sells dental care plans to corporations and/or individuals. It is also involved in commercial advisory, consulting, and business management services; develops and licenses software programs; wholesale and retail trade of products and equipment, sanitizers, drugs, medicines, pharmaceutical inputs, and related items; provision of storage, loading, org... [Read more]

Industry Healthcare Plans

Sector Healthcare

Founded 1987

Employees 1,958

Stock Exchange Brazil Stock Exchange

Ticker Symbol ODPV3

Full Company Profile

Financial Performance

In 2025, Odontoprev's revenue was 2.55 billion, an increase of 5.41% compared to the previous year's 2.41 billion. Earnings were 582.57 million, an increase of 8.03%.

Financial Statements

News

Odontoprev SA (BSP:ODPV3) Q4 2025 Earnings Call Highlights: Robust Growth Amidst Market Challenges

2 months ago - GuruFocus

Q4 2025 Odontoprev SA Earnings Call (English, Portuguese) Transcript

2 months ago - GuruFocus

Odontoprev Earnings Call Transcript: Q4 2025

Reported 5.3% revenue growth and record new lives in 2025, led by SME segment expansion and improved cost efficiency. Integration into a broader health ecosystem marks a new growth phase, with a strong cash position and positive outlook for 2026.

2 months ago - Transcripts

Odontoprev Transcript: Status update

A leading dental plan provider with a technology-driven, asset-light model, strong bank partnerships, and nationwide reach, is expanding its high-margin SME segment while maintaining zero debt and distributing nearly all profits as dividends. Margins and efficiency are rising, with further growth potential in underpenetrated markets and continued focus on technology and shareholder returns.

3 months ago - Transcripts

Odontoprev SA (BSP:ODPV3) Q3 2025 Earnings Call Highlights: Record Growth and Strategic Adjustments

6 months ago - GuruFocus

Q3 2025 Odontoprev SA Earnings Call (English, Portuguese) Transcript

6 months ago - GuruFocus

Odontoprev Earnings Call Transcript: Q3 2025

Net revenue and average ticket rose 7% year-over-year, with record SME growth and a 32% EBITDA margin. CapEx is trending down, and nearly BRL 1.3 billion was distributed to shareholders. SME and individual plans are driving portfolio transformation.

6 months ago - Transcripts

Odontoprev Earnings Call Transcript: Q2 2025

Net revenue reached BRL 2.4 billion, with record SME client growth and a 24% quarterly net income increase. EBITDA margin rose to 34%, and bad debt fell to historic lows, supported by efficient bank channel distribution and disciplined cost control.

9 months ago - Transcripts

Odontoprev Earnings Call Transcript: Q1 2025

Q1 2025 saw strong EBITDA margin expansion to 38.3% and robust cash generation, driven by SME and individual segment growth. Dividend payout remained high at 90% of net profit, and technology CapEx is set to decline. SME and individual plans now account for 60% of contribution margin.

1 year ago - Transcripts

Odontoprev Earnings Call Transcript: Q4 2024

Achieved strong revenue and net income growth in 2024, driven by portfolio diversification, cost efficiency, and robust SME expansion. Dental loss ratio remains below 40%, with high dividend payouts and continued growth expected in under-penetrated segments.